5/26/2020 8:04:29 AM
Teva's Virtual 2020 Annual Meeting To Be Held On June 9
5/25/2020 2:04:29 AM
Teva Pharma Presents New Data On AJOVY At EAN Congress In Populations With Difficult-to-Treat Migraine
5/22/2020 2:16:27 AM
Teva To Present New AJOVY Analyses And Latest COPAXONE Data
5/18/2020 7:05:27 AM
Teva Says China Approves AUSTEDO For Chorea Associated With Huntington's Disease And Tardive Dyskinesia In Adults
5/7/2020 7:03:52 AM
Teva Q1 GAAP EPS $0.06; Non-GAAP EPS $0.76
5/4/2020 8:04:42 AM
Teva Pharma USA, Celltrion Healthcare Unveil Launch Of TRUXIMA Injection For Rheumatoid Arthritis
5/1/2020 8:08:38 AM
Teva Pharma Reports New Data For Teva AJOVY(r) Injection And AUSTEDO(r) Tablets Included In Neurology
4/27/2020 8:03:25 AM
Teva Announces U.S. Launch Of Autoinjector For AJOVY
4/7/2020 7:31:59 AM
Teva Canada Launches Caregiver-Friendly Pharmacy Program
3/19/2020 8:40:19 PM
Teva To Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets To Hospitals Nationwide
3/16/2020 8:03:40 AM
Teva And Celltrion Healthcare Reports US Availability Of HERZUMA
For Injection
3/12/2020 3:38:46 AM
Teva Pharma: NICE Recommends AJOVY In Final Appraisal Document For Prevention Of Migraine With Chronic Migraine